ReShape Lifesciences Inc. received a notice from Nasdaq stating that it no longer complies with listing rules due to not holding an annual meeting of shareholders within 12 months of the end of the 2022 fiscal year.
AI Assistant
RESHAPE LIFESCIENCES INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.